Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations

详细信息    查看全文

• 作者：Tiago A. Mestre ; Erik van Duijn ; Aileen M. Davis ; Anne-Catherine Bachoud-Lé ; vi ; Monica Busse ; Karen E. Anderson ; Joaquim J. Ferreira ; Philipp Mahlknecht ; Vitor Tumas ; Cristina Sampaio ; Chris G. Goetz ; Esther Cubo ; Glenn T. Stebbins ; Pablo Martinez-Martin and the Members of the MDS Committee on Rating Scales Development
• 刊名：Movement Disorders
• 出版年：2016
• 出版时间：October 2016
• 年：2016
• 卷：31
• 期：10
• 页码：1466-1478
• 全文大小：307K
• ISSN：1531-8257

文摘

Behavioral symptoms are an important feature of Huntington's disease and contribute to impairment in quality of life. The Movement Disorder Society commissioned the assessment of the clinimetric properties of rating scales in Huntington's disease to make recommendations regarding their use, following previously used standardized criteria. A systematic literature search was conducted to identify the scales used to assess behavioral symptoms in Huntington's disease. For the purpose of this review, 7 behavioral domains were deemed significant in Huntington's disease: irritability, anxiety, depression, apathy, obsessive-compulsive behaviors, psychosis, and suicidal ideation. We included a total of 27 behavioral rating scales, 19 of which were of a single behavioral domain and the remaining 8 scales included multiple behavioral domains. Three rating scales were classified as “recommended” exclusively for m>screeningm> purposes: the Irritability Scale for irritability, the Beck Depression Inventory-II, and the Hospital Anxiety and Depression Scale for depression. There were no “recommended” scales for other purposes such as diagnosis, severity, or change in time or to treatment. The main challenges identified for assessment of behavioral symptoms in Huntington's disease are the co-occurrence of multiple behavioral symptoms, the particular features of a behavioral symptom in Huntington's disease, and the need to address stage- and disease-specific features, including cognitive impairment and lack of insight. The committee concluded that there is a need to further validate currently available behavioral rating scales in Huntington's disease to address gaps in scale validation for specific behavioral domains and purpose of use.